Related Experiment Videos
Inflammatory bowel disease in children
D von Allmen1, M J Goretsky, M M Ziegler
1University of North Carolina School of Medicine, Department of Surgery, Chapel Hill 27599-7210, USA.
Insights
Recent advancements in pediatric inflammatory bowel disease (IBD) care include new treatments for Crohn's disease and ulcerative colitis. Budesonide shows promise for Crohn's, while surgical techniques improve ulcerative colitis management.
Area of Science:
- Pediatric Gastroenterology
- Surgical Innovation
- Immunology
Background:
- Inflammatory bowel disease (IBD) presents significant challenges in pediatric chronic illness management.
- Current care involves basic science research and refining medical and surgical treatment options.
Purpose of the Study:
- To review recent developments in pediatric inflammatory bowel disease (IBD) care.
- To highlight advancements in medical and surgical treatments for Crohn's disease and ulcerative colitis in children.
Main Methods:
- Review of emerging medical therapies, including steroid analogues for Crohn's disease.
- Analysis of evolving surgical techniques such as strictureplasty and endorectal pull-through for pediatric IBD.
- Investigation into the pathophysiology and complications of ulcerative colitis, specifically pouchitis.
Main Results:
- Budesonide, a novel steroid analogue, demonstrates potential for treating pediatric Crohn's disease with reduced side effects.
- Strictureplasty shows positive outcomes as a bowel-sparing surgical option in children.
- Evolving endorectal pull-through techniques and pouch designs are being reported for ulcerative colitis.
- Research on pouchitis, a common complication, focuses on microbiological, physiological, and immunological factors.
Conclusions:
- Pediatric IBD management benefits from targeted medical therapies like budesonide for Crohn's disease.
- Surgical advancements, including strictureplasty and refined endorectal pull-through, offer improved outcomes for children with IBD.
- Further understanding of pouchitis is crucial for optimizing surgical outcomes in ulcerative colitis.
Abstract:
Inflammatory bowel disease remains a serious chronic illness in children. Recent developments in the care of these patients involves both basic science research into the pathophysiology of ulcerative colitis and Crohn's disease and the development of refinements in the surgical techniques and medical therapies available as treatment options. In Crohn's disease, a new steroid analogue (budesonide) shows some promise as a possible medical treatment that would limit the devastating side effects of steroids in children. In addition, the bowel-sparing technique of strictureplasty has now been reported in children with good results. In ulcerative colitis, the surgical technique of endorectal pull-through continues to evolve with reports of the efficacy of specific pouch designs and surgical techniques. An understanding of pouchitis, the most common complication of endorectal pull-through, has focused on documenting specific alterations in the microbiology and physiology of the pouch, as well as investigating a possible link between autoantibodies and susceptibility to this complication.